Site Selection in Oncology Clinical Trials: Considerations for Selecting Sites in Limited Geographic Regions or Areas of Political Unrest, Limiting Inspection Capabilities (U13) Clinical Trial not allowed.

Department of Health and Human Services Food and Drug Administration
Posted on

Application Deadline

Type

Research/project funding

Reference Number

RFA-FD-23-007

The purpose of this FOA is to support a series of conferences and workshops developed with substantial FDA input to explore challenges regarding site selection of clinical trials sites in studies that are submitted to FDA for regulatory approval of oncology indications.
Categories: Consumer Protection, Science and Technology and other Research and Development.

More Information

Posted on

Application Deadline

Type

Research/project funding

Reference Number

RFA-FD-23-007

United States